← All trials
NCT07042919
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 4, 2026
- Primary completion
- Mar 4, 2029
- Completion date
- Mar 4, 2031
- First posted
- Jun 29, 2025
- Last posted
- Jun 29, 2025
- Enrollment
- 53
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Northwestern UniversityLead sponsor
- National Cancer Institute (NCI)Collaborator
- Northwestern UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.